日韩午夜精品视频,欧美私密网站,国产一区二区三区四区,国产主播一区二区三区四区

Home / China / National News Tools: Save | Print | E-mail | Most Read
167,000 Cases on Illegal Production of Drugs Cracked
Adjust font size:

China uncovered 167,000 cases of illegal production and trade in medicines and medical equipment in the first half of this year, according to the State Food and Drug Administration (SFDA).

A total of 260 million yuan (US$32.5 million) was involved in the cases and more than 200 underground drug production sites were shut down.

Fraudulent pharmaceutical company registration procedures were also detected and punished. The SFDA inspected 14 companies and investigated 131 kinds of drugs between January and June, said head of SFDA Shao Mingli.

Meanwhile, the administration monitored 270,000 illegal advertisements in the public domain of drugs, medical equipment and health foods and reported them to the industrial and commercial authorities.

The administration also punished 20 companies for illegal production during the first half of the year, said Shao.

It is planning to launch a one-year national campaign to regulate the drug market, which will target malpractice in drug research, production, distribution and application as well as slack supervision.

The decision was made after the administration came to the conclusion that the cause of a problematic antibiotic injection case, which left six dead, was improper sterilization during its production.

The "Xinfu" drug, manufactured in June and July by Anhui Huayuan Worldbest Biology Pharmacy Co., wasn't sterilized properly, with both the sterilization temperature and time below the state-required safety level.

The administration has so far recalled more than 1.2 million bottles of the drug, 173,007 are being returned to the factory and more than 403,170 bottles have been sealed up in other areas.

Two months earlier, a fake injection produced by the Qiqihar No. 2 Pharmaceutical Co.,Ltd., a privately-owned business in northeast China's Heilongjiang Province, caused 11 deaths in China.

Both of the companies involved in the two accidents are qualified pharmaceutical companies and their products were sold through legal channels.

The incidents prove that more efforts need to be devoted to checking raw materials, production facilities, workers' qualifications and managers' awareness of responsibilities in the drug industry, said Shao.

(Xinhua News Agency August 16, 2006)

Tools: Save | Print | E-mail | Most Read

Related Stories
Crackdown on Illegal Drug Ads Continues
Using Illegal Drug Increases Among White-collar Workers
Fight Against Illegal Drugs Ratchets Up
FDA Lists Illegal Drug Ads
 
SiteMap | About Us | RSS | Newsletter | Feedback
SEARCH THIS SITE
Copyright ? China.org.cn. All Rights Reserved ????E-mail: webmaster@china.org.cn Tel: 86-10-88828000 京ICP證 040089號
主站蜘蛛池模板: 巫山县| 潢川县| 柯坪县| 江西省| 阿巴嘎旗| 崇文区| 大埔县| 广元市| 广平县| 大城县| 和政县| 忻城县| 始兴县| 平江县| 宿州市| 中西区| 泸溪县| 盐边县| 克山县| 嫩江县| 淅川县| 沧州市| 双桥区| 泽州县| 潜山县| 梁平县| 柯坪县| 理塘县| 金沙县| 汶上县| 苍溪县| 福建省| 建瓯市| 河东区| 同心县| 防城港市| 玉屏| 五常市| 阜康市| 富民县| 安顺市|